SCHEMBL9971789

SCHEMBL9971789

c1ccc(-c2ccc(N(c3ccc(-c4ccc(N(c5ccc(-c6ccccc6)cc5)c5cc6c7ccccc7ccc6c6ccccc56)cc4)cc3)c3cc4c5ccccc5ccc4c4ccccc34)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPRT1 P00492 5/20 0.45
ALDH1A1 P00352 4/20 0.39
HSD17B10 Q99714 3/20 0.39
TSHR P16473 2/20 0.39
CYP2A6 P11509 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CYP1B1 Q16678 4/20 0.38
HIF1A Q16665 1/20 0.38
CYP1A2 P05177 3/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
PAX8 Q06710 1/20 0.35
MAPT P10636 3/20 0.35
NPC1 O15118 1/20 0.35
LMNA P02545 1/20 0.35
RECQL P46063 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CYP1A1 P04798 3/20 0.35
KDM4E B2RXH2 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26053270 1.00 HPRT1 (0.45) HPRT1ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL26053365 0.98 HPRT1 (0.44) HPRT1ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL26053248 0.98 HPRT1 (0.44) HPRT1ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL9971925 0.97 HPRT1 (0.45) HPRT1ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL9971924 0.97 HPRT1 (0.45) HPRT1ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL26053368 0.95 HPRT1 (0.41) HPRT1ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL26053369 0.95 HPRT1 (0.41) HPRT1ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL26053316 0.94 HPRT1 (0.40) HPRT1ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL26053299 0.94 HPRT1 (0.40) HPRT1ALDH1A1HSD17B10TSHRCYP2A6
SCHEMBL26053253 0.94 HPRT1 (0.40) HPRT1ALDH1A1HSD17B10TSHRCYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120153815-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-21 US disclosed
US-20110175521-A1 ORGANIC ELECTROLUMESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2011-07-21 US disclosed
US-20110175521-A1 ORGANIC ELECTROLUMESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2011-07-21 US disclosed
US-20100160687-A1 ORGANIC ELECTROLUMESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2010-06-24 US disclosed
US-20070142671-A1 ORGANIC ELECTROLUMESCENCE DEVICE IDEMITSU KOSAN CO., LTD (JP) 2007-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110175521-A1 ORGANIC ELECTROLUMESCENCE DEVICE SCO2, CHRM1, CHRM4 HPRT1 2868/4885ALDH1A1 2388/4885HSD17B10 2146/4885
US-20100160687-A1 ORGANIC ELECTROLUMESCENCE DEVICE SCO2, CHRM1, CHRM4 HPRT1 2868/4885ALDH1A1 2388/4885HSD17B10 2146/4885
US-20120153815-A1 ORGANIC ELECTROLUMINESCENCE DEVICE ARL1, RIF1, EML4 HPRT1 1563/4885ALDH1A1 699/4885HSD17B10 3421/4885
US-20070142671-A1 ORGANIC ELECTROLUMESCENCE DEVICE SCO2, CHRM1, CHRM4 HPRT1 2868/4885ALDH1A1 2388/4885HSD17B10 2146/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.